Physician profile
Robert B Whitmore
NPI 1366405003
$520.11
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $47.33 · 2021: $28.33 · 2022: $50.78 · 2023: $104 · 2024: $42.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $185.01 | 2019-2020 | |
| Boston Scientific Corporation | $95.78 | 2019-2024 | Lynx System |
| Convatec INC. | $43.79 | 2023 | |
| Astellas Pharma US INC | $30.02 | 2020-2021 | |
| Calyxo, INC. | $26.34 | 2024 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $22.03 | 2022 | |
| Pfizer INC. | $21.49 | 2023 | |
| Alexion Pharmaceuticals, INC. | $21.14 | 2023 | Ultomiris |
| Medtronic, INC. | $18.02 | 2023 | Intellis Adaptivestim |
| Janssen Biotech, INC. | $15.83 | 2019 | |
| Urovant Sciences INC | $15.30 | 2022 | |
| Photocure INC | $13.45 | 2022 | |
| Daiichi Sankyo INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Whitmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.